Loading organizations...
Loading organizations...

AI Agents for Pharmacies
Remedy was founded in 2025 by Vishnu Sreenivasan (Founder) and Sai Mandhan (Founder) and Nikhil Devaraj (Founder).
Remedy has raised $12.0M in total across 2 funding rounds.
Streamline prescription refills, reduce workload, and enhance patient care with intelligent automation.
Remedy was founded in 2025 by Vishnu Sreenivasan (Founder) and Sai Mandhan (Founder) and Nikhil Devaraj (Founder).
Remedy has raised $12.0M in total across 2 funding rounds.
Remedy's investors include Douglas French, 040 Capital, Ambridge Capital, Founder Collective, Freestyle Capital, Goat Capital, Long Journey Ventures, Presence Capital, Spring Capital, Colin Carrier, Emmett Shear, Kevin Lin.
Remedy is a startup founded in 2025 that develops AI agents specifically designed for pharmacies. Its core product streamlines prescription refills, reduces pharmacy staff workload, and enhances patient care through intelligent automation. Remedy serves pharmacies by automating routine tasks such as prescription management and patient communication, addressing operational inefficiencies and improving medication safety. The company is in early stages but shows promise in leveraging AI to transform pharmacy workflows, positioning itself within the growing healthcare AI sector[1].
Remedy was founded in 2025 by Nikhil Devaraj, Sai Mandhan, and Vishnu Sreenivasan, all with strong academic and technical backgrounds, including affiliations with the University of Michigan, NASA, and Brown University. The founders identified the opportunity to apply AI to pharmacy operations to reduce manual burdens and improve patient outcomes. The startup emerged from the recognition that pharmacies face increasing complexity in prescription management and patient adherence, and early traction includes acceptance into Y Combinator’s Fall 2025 batch, signaling investor confidence and access to a strong startup ecosystem[1].
Remedy rides the broader trend of agentic AI transforming healthcare by automating complex, data-intensive tasks. The timing is favorable due to rising demands on pharmacies to improve medication adherence, reduce errors, and optimize operations amid increasing healthcare complexity. AI agents like Remedy’s reduce manual workload and improve decision accuracy, aligning with industry-wide moves toward digital transformation and personalized patient care. This trend is supported by advances in machine learning, natural language processing, and regulatory pressures for safer, more efficient pharmaceutical services[2][3].
Looking ahead, Remedy is well-positioned to expand its AI capabilities to cover broader pharmacy functions such as inventory management, clinical decision support, and patient engagement. The growing adoption of AI in healthcare and pharmacies will likely accelerate Remedy’s growth momentum. Trends such as personalized medicine, real-time patient monitoring, and regulatory compliance automation will shape its evolution. Remedy’s influence could extend beyond pharmacies to integrate with broader healthcare ecosystems, improving outcomes and operational efficiency at scale[2][3].
---
This concise profile highlights Remedy’s mission to revolutionize pharmacy operations with AI, its strong founding team, unique product focus, and alignment with transformative healthcare AI trends.
Key people at Remedy.
Remedy has raised $12.0M across 2 funding rounds. Most recently, it raised $10.0M Series A in June 2019.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jun 26, 2019 | $10.0M Series A | Douglas French | |
| Sep 1, 2016 | $2.0M Seed | 040 Capital, Ambridge Capital, Founder Collective, Freestyle Capital, Goat Capital, Long Journey Ventures, Presence Capital, Spring Capital, Colin Carrier, Emmett Shear, Kevin Lin, Kim Perell, Steve Chen, Tikhon Bernstam |